Analyst Ratings For SLDB – Solid Biosciences (NASDAQ:SLDB)
Today, Leerink Swann reiterated its Outperform rating on SLDB – Solid Biosciences (NASDAQ:SLDB) with a price target of $14.00.
Some recent analyst ratings include
- 4/2/2018-Leerink Swann Reiterated Rating of Outperform .
- 3/15/2018-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Neutral ” rating to a ” Underweight” rating. They now have a $28.00 price target on the stock.
- 2/21/2018-Chardan Capital initiated coverage with a Buy rating.
- 2/20/2018-Instinet initiated coverage with a Buy rating.
- 2/20/2018-Goldman Sachs initiated coverage with a Neutral rating.
Recent Trading Activity for SLDB – Solid Biosciences (NASDAQ:SLDB)
Shares of SLDB – Solid Biosciences closed the previous trading session at with 6.841000080108643 shares trading hands.